LUIS
CAMINAL MONTERO
Investigador/a
Hospital Clinic Barcelona
Barcelona, EspañaPublicaciones en colaboración con investigadores/as de Hospital Clinic Barcelona (8)
2023
-
Predictive Factors of the Use of Rituximab and Belimumab in Spanish Lupus Patients
Medicina (Kaunas, Lithuania), Vol. 59, Núm. 8
-
Spanish cohort of VEXAS syndrome: clinical manifestations, outcome of treatments and novel evidences about UBA1 mosaicism
Annals of the Rheumatic Diseases, Vol. 82, Núm. 12, pp. 1594-1605
2021
-
Tolosa-Hunt Syndrome as an Initial Presentation of Sarcoidosis
Reumatologia Clinica
2017
-
A Genome-wide Association Study Identifies Risk Alleles in Plasminogen and P4HA2 Associated with Giant Cell Arteritis
American Journal of Human Genetics, Vol. 100, Núm. 1, pp. 64-74
-
Very early and early systemic sclerosis in the Spanish scleroderma Registry (RESCLE) cohort
Autoimmunity Reviews, Vol. 16, Núm. 8, pp. 796-802
2016
-
Infection is the major trigger of hemophagocytic syndrome in adult patients treated with biological therapies
Seminars in Arthritis and Rheumatism, Vol. 45, Núm. 4, pp. 391-399
2011
-
Rates of, and risk factors for, severe infections in patients with systemic autoimmune diseases receiving biological agents off-label
Arthritis Research and Therapy, Vol. 13, Núm. 4
2010
-
Off-label use of rituximab in 196 patients with severe, refractory systemic autoimmune diseases
Clinical and Experimental Rheumatology, Vol. 28, Núm. 4, pp. 468-476